Protein kinases and their involvement in the cellular responses to genotoxic stress

Mutation Research - Reviews in Mutation Research

Volumn 543, Issue 1, 2003, Pages 31-58

  Yang, Jun ^a   Yu, Yingnian ^a   Duerksen Hughes, Penelope J ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cell cycle arrest; Genotoxic stress; Mitogen activated protein kinases; Signal transduction pathway

Indexed keywords

ABELSON KINASE; ATM PROTEIN; ATR PROTEIN; DNA DEPENDENT PROTEIN KINASE; METHYLNITRONITROSOGUANIDINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; PROTEIN KINASE; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; TOXIC SUBSTANCE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ATTENUATION; CELL ACTIVATION; CELL CYCLE; CELL DAMAGE; CELL DEATH; CELL FUNCTION; DNA DAMAGE; ENZYME ACTIVATION; GENE EXPRESSION; GENOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION INITIATION;

CELL CYCLE PROTEINS; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MUTAGENS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; STRESS; TUMOR SUPPRESSOR PROTEINS;

EID: 0037223730     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(02)00069-8     Document Type: Review

References (366)

1. 1- and S-phase checkpoints in response to DNA damage. Curr. Opin. Cell Biol. 13:2001;738-747.
2. Dbaibo G.S. Regulation of the stress response by ceramide. Biochem. Soc. Trans. 25:1997;557-561.
3. U. Feige, R.I. Morimoto, I. Yahara, B.S. Polla, Stress-Inducible Cellular Responses, Birkhauser, Basel, Switzerland, 1996.
4. Shackelford R.E., Kaufmann W.K., Paules R.S. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ. Health Perspect. 107(Suppl. 1):1999;5-24.
5. Wang X., Ohnishi T. p53-dependent signal transduction induced by stress. J. Radiat. Res. 38:1997;179-194.
6. Holbrook N.J., Fornace A.J. Response to adversity: molecular control of gene activation following genotoxic stress. New Biologist. 3:1991;825-833.
7. Wang J.Y. Cellular responses to DNA damage. Curr. Opin. Cell Biol. 10:1998;240-247.
8. N.J. Holbrook, Y. Liu, A.J. Fornace, Signaling events controlling the molecular response to genotoxic stress, in: U. Feige, R.I. Morimoto, I. Yahara, B.S. Polla (Eds.), Stress-Inducible Cellular Responses, Birkhauser, Basel, Switzerland, 1996, pp. 273-288.
9. Even G., Littlewood T. A matter of life and cell death. Science. 281:1998;1317-1322.
10. Liu Y., Guyton K.Z., Gorospe M., Xu Q., Lee J.C., Holbrook N.J. Differential activation of ERK, JNK/SAK, and p38/CSBP/PK MAP kinase family members during the cellular response to arsenite. Free Radical Biol. Med. 21:1996;771-781.
11. Yang J., Duerksen-Hughes P.J. A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage. Carcinogenesis. 19:1998;1117-1125.
12. Yang J., Duerksen-Hughes P.J. Activation of a p53-independent, sphingolipid-mediated cytolytic pathway in p53-negative mouse fibroblast cells treated with N-methyl-N-nitro-N-nitrosoguanidine. J. Biol. Chem. 276:2001;27129-27135.
13. Jarvis W.D., Grant S. The role of ceramide in the cellular response to cytotoxic agents. Curr. Opin. Oncol. 10:1998;552-559.
14. Yarosh D.B., Alas L., Kibitel J., O'Conner A., Carrier F., Fornace A.J. Cyclobutane pyrimidine dimers in UV-DNA induce release of soluble mediators that activate the human immunodeficiency virus promoter. J. Invest. Dermatol. 100:1993;190-194.
15. Luethy J.D., Holbrook N.J. Activation of the gadd153 promoter by genotoxic agents: a rapid and specific response to DNA damage. Cancer Res. 52:1992;5-10.
16. Gibbs S., Lohman F., Teubel W., van de Putte P., Backendorf C. Characterization of the human spr2 promoter: induction after UV irradiation or TPA treatment and regulation during differentiation of cultured kereinocytes. Nucleic Acids Res. 18:1990;4401-4407.
17. Smith G.C.M., Jackson S.P. The DNA-dependent protein kinase. Genes Dev. 13:1999;916-934.
18. Jayaraman J., Prives C. Activation of p53 sequence-specific DNA binding by short single strand of DNA requires the p53 C-terminus. Cell. 81:1995;1021-1029.
19. Nelson W.G., Kastan M.B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1994;1815-1823.
20. Zhan Q., El-Deiry W., Bae I., Alamo J.I., Kastan M.B., Vogelstein B., Fornace A.J. Similarity of the DNA-damaging responsiveness and growth suppressive properties of WAF1 to GAD45. Int. J. Oncol. 6:1995;937-946.
21. Devary Y., Rosette D., DiDonato J.A., Karin M. NF-κB activation by ultraviolet light not dependent on a nuclear signal. Science. 275:1993;1442-1445.
22. Stein C.A. Suramin: a novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res. 53:1993;2239-2248.
23. Sachsenmaier C., Radler-Phol A., Zinck R., Nordheim A., Herrlich P., Rahmsdorf H.J. Involvement of growth factor receptors in the mammalian UVC response. Cell. 78:1994;963-972.
24. 2. J. Biol. Chem. 271:1996;4138-4142.
25. Adler V., Yin Z., Tew K.D., Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene. 18:1999;6104-6111.
26. Durocher D., Jackson S.P. DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr. Opin. Cell Biol. 13:2001;225-231.
27. Rotman G., Shiloh Y. ATM: a mediator of multiple responses to genotoxic stress. Oncogene. 18:1999;6135-6144.
28. Chan E.D., Winston B.W., Jarpe M.B., Wynes M.W., Riches D.W. Preferential activation of the p46 isoform of JNK/SAPK in mouse macrophages by TNF alpha. Proc. Natl. Acad. Sci. U.S.A. 94:1997;13169-13174.
29. Bao S., Tibbetts R.S., Brumbaugh K.M., Fang Y., Richardson D.A., Ali A., Chen S.M., Abraham R.T., Wang X.F. ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses. Nature. 411:2001;969-974.
30. Plumb M.A., Smith G.C., Cunniffe S.M., Jackson S.P., O'Neill P. DNA-PK activation by ionizing radiation-induced DNA single-strand breaks. Int. J. Radiat. Biol. 75:1999;553-561.
31. Jackson S.P. DNA-dependent protein kinase. Int. J. Biochem. Cell. Biol. 29:1997;935-938.
32. Gately D.P., Hittle J.C., Chan G.K.T., Yen T.J. Characterization of ATM expression, localization, and associated DNA-dependent protein kinase activity. Mol. Biol. Cell. 9:1998;2361-2374.
33. Lowndes N.F., Murguia J.R. Sensing and responding to DNA damage. Curr. Opin. Genet. Dev. 10:2000;17-25.
34. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15:2001;2177-2196.
35. 1 checkpoint control in the yeast Saccharomyces cerevisiae following exposure to DNA-damaging agents. Genetics. 138:1994;271-281.
36. Pandita T.K., Lieberman H.B., Lim D.S., Dhar S., Zheng W., Taya Y., Kastan M.B. Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene. 19:2000;1386-1391.
37. Andegeko Y., Moyal L., Mittelman L., Tsarfaty I., Shiloh Y., Rotman G. Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem. 276:2001;38224-38230.
38. Wright J.A., Keegan K.S., Herendeen D.R., Bentley N.J., Carr A.M., Hoekstra M.F., Concannon P. Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control. Proc. Natl. Acad. Sci. U.S.A. 95:1998;7445-7450.
39. Hekmat Nejad M., You Z., Yee M.C., Newport J.W., Cimprich K.A. Xenopus ATR is a replication-dependent chromatin-binding protein required for the DNA replication checkpoint. Curr. Biol. 10:2000;1565-1573.
40. Suzuki K., Kodama S., Watanabe M. Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. J. Biol. Chem. 274:1999;25571-25575.
41. Smith G.C., Cary R.B., Lakin N.D., Hann B.C., Teo S.H., Chen D.J., Jackson S.P. Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11134-11139.
42. Guo Z., Kumagai A., Wang S.X., Dunphy W.G. Requirement for ATR in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extract. Genes Dev. 14:2000;2745-2756.
43. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., Qin J. BASC, a super complex of BRCA1-associated proteins: involved in the recognition and repair of aberrant DNA structures. Genes Dev. 14:2000;927-939.
44. Kim G.D., Choi Y.H., Dimtchev A., Jeong S.J., Dritschilo A., Jung M. Sensing of ionizing radiation-induced DNA damage by ATM through interaction with histone deacetylase. J. Biol. Chem. 274:1999;31127-31130.
45. Tibbetts R.S., Cortez D., Brumbaugh K.M., Scully R., Livingston D., Elledge S.J., Abraham R.T. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14:2000;2989-3002.
46. Schmidt D.R., Schreiber S.L. Molecular association between ATR and two components of the nucleosome remodeling and deacetylating complex, HDAC2 and CHD4. Biochemistry. 38:1999;14711-14717.
47. Shiloh Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11:2001;71-77.
48. Matsuoka S., Rotman G., Ogawa A., Shiloh Y., Tamai K., Elledge S. ATM phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. U.S.A. 97:2000;10389-10394.
49. 2/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J. Biol. Chem. 275:2000;10342-10348.
50. Hirao A., Kong Y.-Y., Matsuoka S., Wakeham A., Ruland J., Yoshida H., Liu D., Elledge S.J., Mak T.W. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science. 287:2000;1824-1827.
51. 1 by stabilizing p53. Genes Dev. 14:2000;278-288.
52. Chehab N.H., Malikzay A., Stavridi E.S., Halazonetis T.D. Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 96:1999;13777-13782.
53. Canman C.E., Lim D.-S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1998;1677-1679.
54. Banin S., Moyal L., Shieh S.-Y., Taya Y., Anderson C.W., Chessa L., Smorodinsky N.I., Prives C., Reiss Y., Shiloh Y., Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 281:1998;1674-1677.
55. Nakagawa K., Taya Y., Tamai K., Yamaizumi M. Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. Mol. Cell. Biol. 19:1999;2828-2834.
56. Tibbetts R.S., Brumbaugh K.M., Williams J.M., Sarkaria J.N., Cliby W.A., Shieh S.-Y., Taya Y., Prives C., Abraham R.T. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:1999;152-157.
57. Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y., Shkedy D. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc. Natl. Acad. Sci. U.S.A. 96:1999;14973-14977.
58. de Toledo S.M., Azzam E.I., Dahlberg W.K., Gooding T.B., Little J.B. ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation. Oncogene. 19:2000;6185-6193.
59. Maya R., Balass M., Kim S.T., Shkedy D., Leal J.F., Shifman O., Moas M., Buschmann T., Ronai Z., Shiloh Y., Kastan M.B., Katzir E., Oren M. ATM-dependent phosphorylation of MDM2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15:2001;1067-1077.
60. Kim S.T., Xu B., Kastan M.B. Involvement of the cohesion protein, SMC1, in ATM-dependent and independent responses to DNA damage. Genes Dev. 16:2002;560-570.
61. Wu X., Ranganathan V., Weisman D.S., Heine W.F., Ciccone D.N., O'Neill T.B., Crick K.E., Pierce K.A., Lane W.S., Rathbun G., Livingston D.M., Weaver D.T. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature. 405:2000;477-482.
62. Kishi S., Lu K.P. A critical role for Pin2/TRF1 in ATM-dependent regulation. Inhibition of Pin2/TRF1 function complements telomere shortening, radiosensitivity, and the G(2)/M checkpoint defect of ataxia-telangiectasia cells. J. Biol. Chem. 277:2002;7420-7429.
63. Kishi S., Zhou X.Z., Ziv Y., Khoo C., Hill D.E., Shiloh Y., Lu K.P. Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks. J. Biol. Chem. 276:2001;29282-29291.
64. Wang H., Guan J., Wang H., Perrault A.R., Wang Y., Iliakis G. Replication protein A2 phosphorylation after DNA damage by the coordinated action of ataxia telangiectasia-mutated and DNA-dependent protein kinase. Cancer Res. 61:2001;8554-8563.
65. Chen M.J., Lin Y.T., Lieberman H.B., Chen G., Lee E.Y. ATM-dependent phosphorylation of human Rad9 is required for ionizing radiation-induced checkpoint activation. J. Biol. Chem. 276:2001;16580-16586.
66. Ward I.M., Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 276:2001;47759-47762.
67. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 276:2001;42462-42467.
68. Lin W.C., Lin F.T., Nevins J.R. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15:2001;1833-1844.
69. Zhao H., Piwnica-Worms H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 21:2001;4129-4139.
70. 2/M DNA damage checkpoint. Genes Dev. 14:2000;1448-1459.
71. Gottlieb T.M., Jackson S.P. The DNA-dependent protein kinase: requirement for DNA ends and association with Ku antigen. Cell. 72:1993;131-142.
72. Hartley K., Gell D., Smith G.C., Zhang H., Divecha U., Connelly M.A., Admon A., Lees-Miller S.P., Anderson C.W., Jackson S.P. DNA-dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3-kinase and the ataxia telangiectasia gene product. Cell. 82:1995;849-856.
73. Kanaar R., Hoeijmakers J.H.J., van Gent D.C. Molecular mechanisms of DNA double-strand break repair. Trends Cell Biol. 8:1998;483-489.
74. Critchlow S.E., Jackson S.P. DNA end joining: from yeast to man. Trends Biochem. Sci. 23:1998;394-398.
75. Chu G. Double-strand break repair. J. Biol. Chem. 272:1997;24097-24100.
76. Dynan W.S., Yoo S. Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids. Nucleic Acids Res. 26:1998;1551-1559.
77. Jin S.F., Weaver D.T. Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA binding functions. EMBO J. 16:1997;6874-6885.
78. Hammersten O., Chu G. DNA-dependent protein kinase: DNA binding and activation in the absence of Ku. Proc. Natl. Acad. Sci. U.S.A. 95:1998;525-530.
79. Yavuzer U., Smith G.C., Bliss T., Werner D., Jackson S.P. DNA end-independent activation of DNA-PK mediated via association with the DNA-binding protein C1D. Genes Dev. 12:1998;2188-2199.
80. Yumoto Y., Shirakawa H., Yoshida M., Suwa A., Watanabe F., Teraoka H. High mobility group proteins 1 and 2 can function as DNA-binding regulatory components for DNA-dependent protein kinase in vitro. J. Biochem. (Tokyo). 124:1998;519-527.
81. Huang J., Nueda A., Yoo S., Dynan W.S. Heat shock transcription factor 1 binds selectively in vitro to Ku protein and the catalytic subunit of the DNA-dependent protein kinase. J. Biol. Chem. 272:1997;26009-26016.
82. Myung K., Braastad C., He D.M., Hendrickson E.A. KARP-1 is induced by DNA damage in a p53- and ataxia telangiectasia mutated-dependent fashion. Proc. Natl. Acad. Sci. U.S.A. 95:1998;7664-7669.
83. Myung K., He D.M., Lee S.E., Hendrickson E.A. KARP-1: a novel leucine zipper protein expressed from the Ku86 autoantigen locus is implicated in the control of DNA-dependent protein kinase activity. EMBO J. 16:1997;3172-3184.
84. Lee S.E., Mitchell R.A., Cheng A., Hendrickson E.A. Evidence for DNA-PK-dependent and independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol. Cell. Biol. 17:1997;1425-1433.
85. Jeggo P.A. DNA-PK: at the cross-roads of biochemistry and genetics. Mutat. Res. 384:1997;1-14.
86. Mayo L.D., Turchi J.J., Berberich S.J. MDM-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53. Cancer Res. 57:1997;5013-5016.
87. Karpinich N.O., Tafani M., Rothman R.J., Russo M.A., Farber J.L. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome C. J. Biol. Chem. 277:2002;16547-16552.
88. Achanta G., Pelicano H., Feng L., Plunkett W., Huang P. Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. Cancer Res. 61:2001;8723-8729.
89. Van Etten R.A., Jackson P.K., Baltimore D., Sanders M.C., Matsudaira P.T., Janmey P.A. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124:1994;325-340.
90. Yuan Z., Kharbanda S., Kufe D. 1-β-D-arabinofuranosylcytosine activates the Src-like p56/p53Lyn tyrosine kinase in human myeloid leukemia cells. Biochemistry. 34:1995;1058-1063.
91. Kharbanda S., Yuan Z., Taneja N., Weichselbaum R., Kufe D. p56/p53Lyn tyrosine kinase activation in mammalian cells treated with mitomycin-C. Oncogene. 9:1994;3005-3011.
92. Kharbanda S., Yuan Z., Weichselbaum R., Kufe D. Activation of the Src-like p56/p53Lyn tyrosine kinase by ionizing radiation. J. Biol. Chem. 269:1994;20739-20743.
93. Yoshida K., Weichselbaum R., Kharbanda S., Kufe D. Role for Lyn tyrosine kinase as a regulator of stress-activated protein kinase activity in response to DNA damage. Mol. Cell. Biol. 20:2000;5370-5380.
94. Sanchez-Prieto R., Rojas J.M., Taya Y., Gutkind J.S. A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents. Cancer Res. 60:2000;2464-2472.
95. Sanchez-Perez I., Murguia J.R., Perona R. Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene. 16:1998;533-540.
96. Fritz G., Kaina B. Activation of c-Jun N-terminal kinase 1 by UV irradiation is inhibited by wortmannin without affecting c-Jun expression. Mol. Cell. Biol. 19:1999;1768-1774.
97. Pillaire M.J., Nebreda A.R., Darbon J.M. Cisplatin and UV radiation induce activation of the stress-activated protein kinase p38gamma in human melanoma cells. Biochem. Biophys. Res. Commun. 278:2000;724-728.
98. 2/M checkpoint after ultraviolet radiation requires p38 kinase. Nature. 411:2001;102-107.
99. Takahashi S., Saito S., Ohtani N., Sakai T. Involvement of the Oct-1 regulatory element of the gadd45 promoter in the p53-independent response to ultraviolet irradiation. Cancer Res. 61:2001;1187-1195.
100. Uberti D., Schwartz D., Almog N., Goldfinger N., Harmelin A., Memo M., Rotter V. Epithelial cells of different organs exhibit distinct patterns of p53-dependent and p53-independent apoptosis following DNA insult. Exp. Cell Res. 252:1999;123-133.
101. 2/M-associated cell death after gamma-irradiation. Oncogene. 14:1997;2759-2766.
102. 2/M checkpoint symphony. Curr. Opin. Genet. Dev. 12:2002;92-97.
103. Bartek J., Falck J., Lukas J. Chk2 kinase - a busy messenger. Nat. Rev. Mol. Cell. Biol. 2:2001;877-886.
104. Li A., Blow J.J. The origin of CDK regulation. Nat. Cell. Biol. 3:2001;E182-184.
105. McGowan C.H. Checking in on Cds1 (Chk2): a checkpoint kinase and tumor suppressor. Bioessays. 24:2002;502-511.
106. Olashaw N., Pledger W.J. Paradigms of growth control: relation to Cdk activation. Sci. STKE. 134:2002;RE7.
107. Walworth N.C. DNA damage: Chk1 and Cdc25, more than meets the eye. Curr. Opin. Genet. Dev. 11:2001;78-82.
108. Goff S.P., Gilboa E., Witte O.N., Baltimore D. Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: studies with cloned viral DNA. Cell. 22:1980;777-785.
109. Abelson H.T., Rabstein L.S. Lymphosarcoma: virus-induced thymic-independent disease in mice. Cancer Res. 30:1970;2213-2222.
110. Wen S.-T., Van Etten R.A. The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev. 11:1997;2456-2467.
111. Liu Z.G., Baskaran R., Lea-Chou E.T., Wood L.D., Chen Y., Karin M., Wang J.Y. Three distinct signalling responses by murine fibroblasts to genotoxic stress. Nature. 384:1996;273-276.
112. Kharbanda S., Ren R., Pandey P., Shafman T.D., Feller S.M., Weichselbaum R.R., Kufe D.W. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature. 376:1995;785-788.
113. Shafman T., Khanna K.K., Kedar P., Spring K., Kozlov S., Yen T., Hobson K., Gatei M., Zhang N., Watters D., Egerton M., Shiloh Y., Kharbanda S., Kufe D., Lavin M.F. Interaction between ATM protein and c-Abl in response to DNA damage. Nature. 387:1997;520-523.
114. Baskaran R., Wood L.D., Whitaker L.L., Xu Y., Barlow C., Canman C.E., Morgan S.E., Baltimore D., Wynshan-Boris A., Kastan M.B., Wang J.Y.J. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature. 387:1997;516-519.
115. Takao N., Mori R., Kato H., Shinohara A., Yamamoto K. c-Abl tyrosine kinase is not essential for ataxia telangiectasia mutated functions in chromosomal maintenance. J. Biol. Chem. 275:2000;725-728.
116. Kharbanda S., Pandey P., Jin S., Inoue S., Bharti A., Yuan Z.M., Weichselbaum R., Weaver D., Kufe D. Functional interaction of DNA-PK and c-Abl in response to DNA damage. Nature. 386:1997;732-735.
117. Shangary S., Brown K.D., Adamson A.W., Edmonson S., Ng B., Pandita T.K., Yalowich J., Taccioli G.E., Baskaran R. Regulation of DNA-dependent protein kinase activity by ionizing radiation-activated Abl kinase is an ATM-dependent process. J. Biol. Chem. 275:2000;30163-30168.
118. Yuan Z.M., Huang Y., Whang Y., Sawyers C., Weichselbaum R., Kharbanda S., Kufe D. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage. Nature. 382:1996;272-274.
119. Wen S.-T., Jackson P.K., Van Etten R.A. The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products. EMBO J. 15:1996;1583-1595.
120. Huang Y., Yuan Z.M., Ishiko T., Nakada S., Utsugisawa T., Kato T., Kharbanda S., Kufe D.W. Pro-apoptotic effect of the c-Abl tyrosine kinase in the cellular response to 1-beta-D-arabinofuranosylcytosine. Oncogene. 15:1997;1947-1952.
121. Yuan Z.M., Huang Y., Ishiko T., Kharbanda S., Weichselbaum R., Kufe D. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;1437-1440.
122. Shaul Y. c-Abl: activation and nuclear targets. Cell Death Differ. 7:2000;10-16.
123. Gong J.G., Costanzo A., Yang H.Q., Melino G., Kaelin W.G.J., Levrero M., Wang J.Y. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:1999;806-809.
124. Agami R., Blandino G., Oren M., Shaul Y. Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature. 399:1999;809-813.
125. Sionov R.V., Moallem E., Berger M., Kazaz A., Gerlitz O., Ben-Neriah Y., Oren M., Haupt Y. c-Abl neutralizes the inhibitory effect of MDM2 on p53. J. Biol. Chem. 274:1999;8371-8374.
126. Sionov R.V., Coen S., Goldberg Z., Berger M., Bercovich B., Ben-Neriah Y., Ciechanover A., Haupt Y. c-Abl regulates p53 levels under normal and stress conditions by preventing its nuclear export and ubiquitination. Mol. Cell. Biol. 21:2001;5869-5878.
127. Cong F., Goff S.P. c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation. Proc. Natl. Acad. Sci. U.S.A. 96:1999;13819-13824.
128. Kharbanda S., Pandey P., Yamauchi T., Kumar S., Kaneki M., Kumar V., Bharti A., Yuan Z.M., Ghanem L., Rana A., Weichselbaum R., Johnson G., Kufe D. Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage. Mol. Cell. Biol. 20:2000;4979-4989.
129. Gustin M.C., Albertyn J., Alexander M., Davenport K. MAP kinase pathways in the yeast Saccharomyces cerevisiae. Mol. Cell. Biol. Rev. 62:1998;1264-1300.
130. Abe M.K., Kuo W.L., Hershenson M.B., Rosner M.R. Extracellular signal-regulated kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its cellular localization, and cell growth. Mol. Cell. Biol. 19:1999;1301-1312.
131. Zimmermann J., Lamerant N., Grossenbacher R., Furst P. Proteasome- and p38-dependent regulation of ERK3 expression. J. Biol. Chem. 276:2001;10759-10766.
132. Turgeon B., Saba-El-Leil M.K., Meloche S. Cloning and characterization of mouse extracellular-signal-regulated protein kinase 3 as a unique gene product of 100 kDa. Biochem. J. 346:2000;169-175.
133. Robinson M.J., Xu B.E., Stippec S., Cobb M.H. Different domains of the mitogen-activated protein kinases ERK3 and ERK2 direct subcellular localization and upstream specificity in vivo. J. Biol. Chem. 277:2002;5094-5100.
134. Abe M.K., Saelzler M.P., Espinosa R. 3rd, Kahle K.T., Hershenson M.B., Le Beau M.M., Rosner M.R. ERK8, a new member of the MAP kinase family. J. Biol. Chem. 277:2002;16733-16743.
135. Garrington T.P., Johnson G.L. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11:1999;211-218.
136. Hagemann C., Blank J.L. The ups and downs of MEK kinase interactions. Cell Signal. 13:2001;863-875.
137. Ballif B.A., Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ. 12:2001;397-408.
138. Cano E., Mahadevan L.C. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:1995;117-122.
139. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:1997;180-186.
140. Schaeffer H.J., Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19:1999;2435-2444.
141. Ito Y., Pandey P., Sathyanarayana P., Ling P., Rana A., Weichselbaum R., Tan T.H., Kufe D., Kharbanda S. Interaction of hematopoietic progenitor kinase 1 and c-Abl tyrosine kinase in response to genotoxic stress. J. Biol. Chem. 276:2001;18130-18138.
142. Wang X., McGowan C.H., Zhao M., He L., Downey J.S., Fearns C., Wang Y., Huang S., Han J. Involvement of the MKK6-p38γ cascade in γ-radiation-induced cell cycle arrest. Mol. Cell. Biol. 20:2000;4543-4552.
143. Liu R.Y., Fan C., Liu G., Olashaw N.E., Zuckerman K.S. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-α-supported proliferation of leukemia and lymphoma cell lines. J. Biol. Chem. 275:2000;21086-21093.
144. Rosette C., Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science. 274:1996;1194-1197.
145. Herrlich P., Sachsenmaire C., Radler-Pohl A., Gebel S., Blattner C., Rahmsdorf H.J. The mammalian UV response: mechanism of DNA damage induced gene expression. Adv. Enzyme Regulat. 34:1994;381-395.
146. Blattner C., Knebel A., Radler-Phol A., Sachsenmaier C., Herrlich P., Rahmsdorf H.J. DNA damaging agents and growth factors induced changes in the program of expressed gene products through common routes. Environ. Mol. Mutagen. 24:1994;3-10.
147. Meighan Mantha R.L., Wellstein A., Riegel A.T. Differential regulation of extracellular signal-regulated kinase 1 and 2 activity during 12-O-tetradecanoylphorbol 13-acetate-induced differentiation of HL-60 cells. Exp. Cell. Res. 234:1997;321-328.
148. Ludwig S., Hoffmeyer A., Goebeler M., Kilian K., Hafner H., Neufeld B., Han J., Rapp U.R. The stress inducer arsenite activates mitogen-activated protein kinases extracellular signal-regulated kinases 1 and 2 via a MAPK kinase 6/p38-dependent pathway. J. Biol. Chem. 273:1996;1917-1922.
149. Wilhelm D., Bender K., Knebel A., Angel P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol. Cell. Biol. 17:1997;4792-4800.
150. Tang D., Wu D., Hirao A., Lahti J.M., Liu L., Mazza B., Kidd V.J., Mak T.W., Ingram A.J. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277:2002;12710-12717.
151. Davis R.J. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:1993;14553-14556.
152. Avruch J., Zhang X.F., Kyriakis J.M. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19:1994;279-283.
153. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
154. Yung Y., Yao Z., Hanoch T., Seger R. ERK1b, a 46-kDa ERK isoform that is differentially regulated by MEK. J. Biol. Chem. 275:2000;15799-15808.
155. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351:2000;289-305.
156. Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K.L. Kinase suppressor of Ras forms a multi-protein signaling complex and modulates MEK localization. Mol. Cell. Biol. 19:1999;5523-5534.
157. Therrien M., Michaud N.R., Rubin G.M., Morrison D.K. KSR modulates signal propagation within the MAPK cascade. Genes Dev. 10:1996;2684-2695.
158. Yu W., Fantl W.J., Harrowe G., Willams L.T. Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK. Curr. Biol. 8:1998;56-64.
159. Roy F., Laberge G., Douziech M., Ferland-McCollough D., Therrien M. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 16:2002;427-438.
160. English J., Pearson G., Wilsbacher J., Swantek J., Karandikar M., Xu S., Cobb M.H. New insights into the control of MAP kinase pathways. Exp. Cell. Res. 253:1999;255-270.
161. Cacace A.M., Michaud N.R., Therrien M., Mathes K., Copeland T., Rubin G.M., Morrison D.K. Identification of constitutive and Ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. Mol. Cell. Biol. 19:1999;229-240.
162. Michaud N.R., Therrien M., Cacace A., Edsall L.C., Spiegel S., Rubin G.M., Morrison D.K. KSR stimulates Raf-1 activity in a kinase-independent manner. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7982-7986.
163. Schaeffer H.J., Catling A.D., Eblen S.T., Collier L.S., Krauss A., Weber M.J. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science. 281:1998;1668-1671.
164. Karandikar M., Xu S., Cobb M.H. MEKK1 binds Raf-1 and the ERK2 cascade components. J. Biol. Chem. 275:2000;40120-40127.
165. Lewis T.S., Shapiro P.S., Ahn N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:1998;49-139.
166. Slagsvold H.H., Ostvold A.C., Fallgren A.B., Paulsen R.E. Nuclear receptor and apoptosis initiator NGFI-B is a substrate for kinase ERK2. Biochem. Biophys. Res. Commun. 291:2002;1146-1150.
167. Benkhelifa S., Provot S., Nabais E., Eychene A., Calothy G., Felder-Schmittbuhl M.P. Phosphorylation of MafA is essential for its transcriptional and biological properties. Mol. Cell. Biol. 21:2001;4441-4452.
168. Jacobs D., Glossip D., Xing H., Muslin A.J., Kornfeld K. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev. 13:1999;163-175.
169. Yang S.H., Whitmarsh A.J., Davis R.J., Sharrocks A.D. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J. 17:1998;1740-1749.
170. Barsyte-Lovejoy D., Galanis A., Sharrocks A.D. Specificity determinants in MAP kinase signaling to transcription factors. J. Biol. Chem. 277:2002;9896-9903.
171. Smith J.A., Poteet-Smith C.E., Malarkey K., Sturgill T.W. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J. Biol. Chem. 274:1999;2893-2898.
172. Wang S., Shi X. Mechanisms of Cr(VI)-induced p53 activation: the role of phosphorylation, MDM2 and ERK. Carcinogenesis. 22:2001;757-762.
173. Persons D.L., Yazlovitskaya E.M., Pelling J.C. Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J. Biol. Chem. 275:2000;35778-35785.
174. Bacus S.S., Gudkov A.V., Lowe M., Lyass L., Yung Y., Komarov A.P., Keyomarsi K., Yarden Y., Seger R. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene. 20:2001;147-155.
175. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that bind and potentiate the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
176. Mielke K., Damm A., Yang D.D., Herdegen T. Selective expression of JNK isoforms and stress-specific JNK activity in different neural cell lines. Brain Res. Mol. Brain Res. 75:2000;128-137.
177. Dreskin S.C., Thomas G.W., Dale S.N., Heasley L.E. Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells. J. Immunol. 166:2001;5646-5653.
178. Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K., Derijard B., Davis R.J. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:1996;2760-2770.
179. Derijard B., Raingeaud J., Barrett T., Wu I.H., Han J., Ulevitch R.J., Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1994;1025-1037.
180. Barr R.K., Bogoyevitch M.A. The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs). Int. J. Biochem. Cell Biol. 33:2001;1047-1063.
181. Han S.I., Ha K.S., Kang K.I., Kim H.D., Kang H.S. Heat shock-induced actin polymerization, SAPK/JNK activation, and heat-shock protein expression are mediated by genistein-sensitive tyrosine kinase(s) in K562 cells. Cell. Biol. Int. 24:2000;447-457.
182. Han S.I., Oh S.Y., Woo S.H., Kim K.H., Kim J.H., Kim H.D., Kang H.S. Implication of a small GTPase Rac1 in the activation of c-Jun N-terminal kinase and heat shock factor in response to heat shock. J. Biol. Chem. 276:2001;1889-1895.
183. Park J., Liu A.Y. JNK phosphorylates the HSF1 transcriptional activation domain: role of JNK in the regulation of the heat shock response. J. Cell. Biochem. 82:2001;326-338.
184. Potapova O., Haghighi A., Bost F., Liu C., Birrer M.J., Gjerset R., Mercola D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem. 272:1997;14041-14044.
185. 2-terminal kinase and p38 mitogen-activated protein kinases by methyl methane sulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis. Cancer Res. 60:2000;5067-5073.
186. Finch A., Davis W., Carter W.G., Saklatvala J. Analysis of mitogen-activated protein kinase pathways used by interleukin 1 in tissues in vivo: activation of hepatic c-Jun N-terminal kinases 1 and 2, and mitogen-activated protein kinase kinase 4 and 7. Biochem. J. 353:2001;275-281.
187. 2-terminal kinase-1 and antagonizes PDGF receptor-beta-induced phenotypic transformation. J. Biol. Chem. 275:2000;19076-19082.
188. Bost F., McKay R., Bost M., Potapova O., Dean N.M., Mercola D. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol. Cell. Biol. 19:1999;1938-1949.
189. Bost F., McKay R., Dean N., Mercola D. The Jun kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem. 272:1997;33422-33429.
190. Flemming Y., Armstrong C.G., Morrice N., Paterson A., Goedert M., Cohen P. Synergistic activation of stress-activated protein kinase 1/c-Jun terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem. J. 352:2000;145-154.
191. 2-terminal kinase kinase. Mol. Cell. Biol. 19:1999;1569-1581.
192. Shirakabe K., Yamaguchi K., Shibuya H., Irie K., Matsuda S., Moriguchi T., Matsumoto K., Nishida E. TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase. J. Biol. Chem. 272:1997;8141-8144.
193. Ichijo H., Nishida E., Irie K., ten Dijke P., Saitoh M., Moriguchi T., Takagi M., Matsumoto K., Miyazono K., Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science. 275:1997;90-94.
194. Salmeron A., Ahmad T.B., Carlile G.W., Pappin D., Narimhan R.P., Ley S.C. Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase. EMBO J. 15:1996;817-826.
195. Tanaka S., Hanafusa H. Guanin-nucleotide exchange protein C3G activates JNK1 by a Ras-independent mechanism. JNK1 activation inhibited by kinase negative forms of MLK3 and DLK mixed lineage kinases. J. Biol. Chem. 273:1998;1281-1284.
196. Roig J., Traugh J.A. p21-activated protein kinase gamma-PAK is activated by ionizing radiation and other DNA-damaging agents. Similarities and differences to alpha-PAK. J. Biol. Chem. 274:1999;31119-31122.
197. Ivanov V.N., Kehrl J.H., Ronai Z. Role of TRAF2/GCK in melanoma sensitivity to UV-induced apoptosis. Oncogene. 19:2000;933-942.
198. Yao Z., Zhou G., Wang X.S., Brown A., Diener K., Gan H., Tan T.H. A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway. J. Biol. Chem. 274:1999;2118-2125.
199. Zhang Y., Ma W.Y., Kaji A., Bode A.M., Dong Z. Requirement of ATM in UVA-induced signaling and apoptosis. J. Biol. Chem. 277:2002;3124-3131.
200. Whitmarsh A.J., Cavanagh J., Tournier C., Yasuda J., Davis R.J. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 281:1998;1671-1674.
201. Dickens M., Rogers J.S., Cavanagh J., Raitano A., Xia Z., Halpern J.R., Greenberg M.E., Sawyers C.L., Davis R.J. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science. 277:1997;693-696.
202. Tawadros T., Formenton A., Dudler J., Thompson N., Nicod P., Leisinger H.J., Waeber G., Haefliger J.A. The scaffold protein IB1/JIP-1 controls the activation of JNK in rat stressed urothelium. J. Cell Sci. 115:2002;385-393.
203. Ikeda A., Hasegawa K., Masaki M., Moriguchi T., Nishida E., Kozutsumi Y., Oka S., Kawasaki T. Mixed lineage kinase LZK forms a functional signaling complex with JIP-1, a scaffold protein of the c-Jun NH(2)-terminal kinase pathway. J. Biochem. (Tokyo). 130:2001;773-781.
204. Nihalani D., Meyer D., Pajni S., Holzman L.B. Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components. EMBO J. 20:2001;3447-3458.
205. Kim I.J., Lee K.W., Park B.Y., Lee J.K., Park J., Choi I.Y., Eom S.J., Chang T.S., Kim M.J., Yeom Y.I., Chang S.K., Lee Y.D., Choi E.J., Han P.L. Molecular cloning of multiple splicing variants of JIP-1 preferentially expressed in brain. J. Neurochem. 72:1999;1335-1343.
206. Yasuda J., Whitmarsh A.J., Cavanagh J., Sharma M., Davis R.J. The JIP group of mitogen-activated protein kinase scaffold proteins. Mol. Cell. Biol. 19:1999;7245-7254.
207. Kelkar N., Gupta S., Dickens M., Davis R.J. Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. Mol. Cell. Biol. 20:2000;1030-1043.
208. Ito M., Yoshioka K., Akechi M., Yamashita S., Takamatsu N., Sugiyama K., Hibi M., Nakabeppu Y., Shiba T., Yamamoto K.I. JSAP1, a novel Jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway. Mol. Cell. Biol. 19:1999;7539-7548.
209. Bonny C., Nicod P., Waeber G. IB1, a JIP-related nuclear protein present in insulin-secreting cells. J. Biol. Chem. 273:1998;1843-1846.
210. Ito M., Akechi M., Hirose R., Ichimura M., Takamatsu N., Xu P., Nakabeppu Y., Tadayoshi S., Yamamoto K., Yoshioka K. Isoforms of JSAP1 scaffold protein generated through alternative splicing. Gene. 255:2000;229-234.
211. Akechi M., Ito M., Uemura K., Takamatsu N., Yamashita S., Uchiyama K., Yoshioka K., Shiba T. Expression of JNK cascade scaffold protein JSAP1 in the mouse nervous system. Neurosci. Res. 39:2001;391-400.
212. 2-terminal kinase signaling pathways suppresses the extracellular signal-regulated kinase signaling pathways. J. Biol. Chem. 275:2000;39815-39818.
213. Koyano S., Ito M., Takamatsu N., Shiba T., Yamamoto K., Yoshioka K. A novel Jun N-terminal kinase (JNK)-binding protein that enhances the activation of JNK by MEK kinase 1 and TGF-beta-activated kinase 1. FEBS Lett. 457:1999;385-388.
214. Cheng J., Yang J., Xia Y., Karin M., Su B. Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation. Mol. Cell. Biol. 20:2000;2334-2342.
215. Kallunki T., Deng T., Hibi M., Karin M. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 87:1996;929-939.
216. Atfi A., Buisine M., Mazars A., Gespach C. Induction of apoptosis by DPC4, a transcriptional factor regulated by transforming growth factor-beta through stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signaling pathway. J. Biol. Chem. 272:1997;24731-24734.
217. Chow C.W., Rincon M., Cavanagh J., Dickens M., Davis R.J. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science. 278:1997;1638-1641.
218. Fuchs S.Y., Adler V., Pincus M.R., Ronai Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. U.S.A. 95:1998;10541-10546.
219. 2-terminal kinase, p14ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiation. Cancer Res. 60:2000;896-900.
220. 2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21:2001;2743-2754.
221. Fuchs S.Y., Adler V., Buschmann T., Yin Z., Wu X., Jones S.N., Ronai Z. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev. 12:1998;2658-2663.
222. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., Bar-Sagi D., Jones S.N., Flavell R.A., Davis R.J. Requirement of JNK for stress-induced activation of the cytochrome C-mediated death pathway. Science. 288:2000;870-874.
223. Kharbanda S., Saxena S., Yoshida K., Pandey P., Kaneki M., Wang Q., Cheng K., Chen Y.N., Campbell A., Sudha T., Yuan Z.M., Narula J., Weichselbaum R., Nalin C., Kufe D. Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage. J. Biol. Chem. 275:2000;322-327.
224. Kharbanda S., Pandey P., Schofield L., Israels S., Roncinske R., Yoshida K., Bharti A., Yuan Z.M., Saxena S., Weichselbaum R., Nalin C., Kufe D. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;6342-6939.
225. Sudo T., Yagasaki Y., Hama H., Watanabe N., Osada H. Exip, a new alternative splicing variant of p38alpha, can induce an earlier onset of apoptosis in HeLa cells. Biochem. Biophys. Res. Commun. 291:2002;838-843.
226. Garmyn M., Mammone T., Pupe A., Gan D., Declercq L., Maes D. Human keratinocytes respond to osmotic stress by p38 map kinase regulated induction of Hsp70 and Hsp27. J. Invest. Dermatol. 117:2001;1290-1295.
227. Rosenberger J., Petrovics G., Buzas B. Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38- and ERK-MAP kinases and NF-kappaB. J. Neurochem. 79:2001;35-44.
228. Suzuki K., Hino M., Kutsuna H., Hato F., Sakamoto C., Takahashi T., Tatsumi N., Kitagawa S. Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1beta. J. Immunol. 167:2001;5940-5947.
229. McDermott E.P., O'Neill L.A. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1. J. Biol. Chem. 277:2002;7808-7815.
230. Zu Y.L., Qi J., Gilchrist A., Fernandez G.A., Vazquez-Abad D., Kreutzer D.L., Huang C.K., Sha'afi R.I. p38 mitogen-activated protein kinase activation is required for human neutrophil function triggered by TNF-alpha or fMLP stimulation. J. Immunol. 160:1998;1982-1989.
231. Nebreda A.R., Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25:2000;257-260.
232. van den Blink B., Juffermans N.P., ten Hove T., Schultz M.J., van Deventer S.J., van der Poll T., Peppelenbosch M.P. p38 mitogen-activated protein kinase inhibition increases cytokine release by macrophages in vitro and during infection in vivo. J. Immunol. 166:2001;582-587.
233. Feng Y., Schreiner G.F., Chakravarty S., Liu D.Y., Joly A.H. Inhibition of the mitogen activated protein kinase, p38 alpha, prevents proinflammatory cytokine induction by human adherent mononuclear leukocytes in response to lipid loading. Atherosclerosis. 158:2001;331-338.
234. Underwood D.C., Osborn R.R., Kotzer C.J., Adams J.L., Lee J.C., Webb E.F., Carpenter D.C., Bochnowicz S., Thomas H.C., Hay D.W., Griswold D.E. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence. J. Pharmacol. Exp. Ther. 293:2000;281-288.
235. Salituro F.G., Germann U.A., Wilson K.P., Bemis G.W., Fox T., Su M.S. Inhibitors of p38 MAP kinase: therapeutic intervention in cytokine-mediated diseases. Curr. Med. Chem. 6:1999;807-823.
236. Matsumoto K., Hashimoto S., Gon Y., Nakayama T., Horie T. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway. J. Allergy Clin. Immunol. 101:1998;825-831.
237. Lee J.C., Kumar S., Griswold D.E., Underwood D.C., Votta B.J., Adams J.L. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology. 47:2000;185-201.
238. Sanchez-Prieto R., Sanchez-Arevalo V.J., Servitja J.M., Gutkind J.S. Regulation of p73 by c-Abl through the p38 MAP kinase pathway. Oncogene. 21:2002;974-979.
239. Pandey P., Raingeaud J., Kaneki M., Weichselbaum R., Davis R.J., Kufe D., Kharbanda S. Activation of p38 mitogen-activated protein kinase by c-Abl-dependent and -independent mechanisms. J. Biol. Chem. 271:1996;23775-23779.
240. Dechert M.A., Holder J.M., Gerthoffer W.T. p21-activated kinase 1 participates in tracheal smooth muscle cell migration by signaling to p38 MAPK. Am. J. Physiol. Cell Physiol. 281:2001;C123-C132.
241. Lee S.H., Eom M., Lee S.J., Kim S., Park H.J., Park D. BetaPix-enhanced p38 activation by Cdc42/Rac/PAK/MKK3/6-mediated pathway. Implication in the regulation of membrane ruffling. J. Biol. Chem. 276:2001;25066-25072.
242. 2-terminal kinase (JNK) and p38. Germinal center kinase couples TRAF2 to mitogen-activated protein kinase/ERK kinase kinase 1 and SAPK while receptor interacting protein associates with a mitogen-activated protein kinase kinase kinase upstream of MKK6 and p38. J. Biol. Chem. 273:1998;22681-22692.
243. Schaefer B.C., Ware M.F., Marrack P., Fanger G.R., Kappler J.W., Johnson G.L., Monks C.R. Live cell fluorescence imaging of T cell MEKK2: redistribution and activation in response to antigen stimulation of the T cell receptor. Immunity. 11:1999;411-421.
244. 2-terminal kinases. J. Biol. Chem. 274:1999;16604-16610.
245. 2-terminal kinase 1 and MKK3/p38 pathways regulated by MEK kinases 2 and 3. MEK kinase 3 activates MKK3 but does not cause activation of p38 kinase in vivo. J. Biol. Chem. 272:1997;14489-14496.
246. Lee H., Jiang F., Wang Q., Nicosia S.V., Yang J., Su B., Bai W. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells. Mol. Endocrinol. 14:2000;1882-1896.
247. Wang C., Deng L., Hong M., Akkaraju G.R., Inoue J., Chen Z.J. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature. 412:2001;346-351.
248. Sayama K., Hanakawa Y., Shirakata Y., Yamasaki K., Sawada Y., Sun L., Yamanishi K., Ichijo H., Hashimoto K. Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular inducer of keratinocyte differentiation. J. Biol. Chem. 276:2001;999-1004.
249. Tibbles L.A., Ing Y.L., Kiefer F., Chan J., Iscove N., Woodgett J.R., Lassam N.J. MLK-3 activates the SAPK/JNK and p38/RK pathways via SEK1 and MKK3/6. EMBO J. 15:1996;7026-7035.
250. Enslen H., Brancho D.M., Davis R.J. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J. 19:2000;1301-1311.
251. Alonso G., Ambrosino C., Jones M., Nebreda A.R. Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J. Biol. Chem. 275:2000;40641-40648.
252. Navarro L., David M. p38-dependent activation of interferon regulatory factor 3 by lipopolysaccharide. J. Biol. Chem. 274:1999;35535-35538.
253. Obata T., Brown G.E., Yaffe M.B. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit. Care Med. 28:2000;N67-N77.
254. Martin-Blanco E. p38 MAPK signalling cascades: ancient roles and new functions. Bioessays. 22:2000;637-645.
255. Bulavin D.V., Saito S., Hollander M.C., Sakaguchi K., Anderson C.W., Appella E., Fornace A.J. Jr. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18:1999;6845-6854.
256. Keller D., Zeng X., Li X., Kapoor M., Iordanov M.S., Taya Y., Lozano G., Magun B., Lu H. The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. Biochem. Biophys. Res. Commun. 261:1999;464-471.
257. She Q.B., Chen N., Dong Z. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J. Biol. Chem. 275:2000;20444-20449.
258. Tanoue T., Maeda R., Adachi M., Nishida E. Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J. 20:2001;466-479.
259. Iordanov M., Bender K., Ade T., Schmid W., Sachsenmaier C., Engel K., Gaestel M., Rahmsdorf H.J., Herrlich P. CREB is activated by UVC through a p38/HOG-1-dependent protein kinase. EMBO J. 16:1997;1009-1022.
260. Heidenreich O., Neininger A., Schratt G., Zinck R., Cahill M.A., Engel K., Kotlyarov A., Kraft R., Kostka S., Gaestel M., Nordheim A. MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. J. Biol. Chem. 274:1999;14434-14443.
261. Huang C.K., Zhan L., Ai Y., Jongstra J. LSP1 is the major substrate for mitogen-activated protein kinase-activated protein kinase 2 in human neutrophils. J. Biol. Chem. 272:1997;17-19.
262. Cuenda A., Cohen P., Buee-Scherrer V., Goedert M. Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16:1997;295-305.
263. Zu Y.L., Ai Y., Gilchrist A., Labadia M.E., Sha'afi R.I., Huang C.K. Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation. Blood. 87:1996;5287-5296.
264. Frodin M., Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Mol. Cell. Endocrinol. 151:1999;65-77.
265. rsk/MAPKAP-K1 via ERK and JNK pathways. J. Biol. Chem. 276:2001;14572-14580.
266. Deak M., Clifton A.D., Lucocq L.M., Alessi D.R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17:1998;4426-4441.
267. Rolli M., Kotlyarov A., Sakamoto K.M., Gaestel M., Neininger A. Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAmp-responsive promoter element in a MAPKAP kinase 2-independent manner. J. Biol. Chem. 274:1999;19559-19564.
268. Waskiewicz A.J., Flynn A., Proud C.G., Cooper J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1997;1909-1920.
269. Pyronnet S., Imataka H., Gingras A.C., Fukunaga R., Hunter T., Sonenberg N. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J. 18:1999;270-279.
270. Fukunaga R., Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16:1997;1921-1933.
271. Pierrat B., Correia J.S., Mary J.L., Tomas-Zuber M., Lesslauer W. RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alphaMAPK). J. Biol. Chem. 273:1998;29661-29671.
272. Tomas-Zuber M., Mary J.L., Lamour F., Bur D., Lesslauer W. C-terminal elements control location, activation threshold, and p38 docking of ribosomal S6 kinase B (RSKB). J. Biol. Chem. 276:2001;5892-5899.
273. New L., Jiang Y., Zhao M., Liu K., Zhu W., Flood L.J., Kato Y., Parry G.C., Han J. PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J. 17:1998;3372-3384.
274. Nadkarni V., Gabbay K.H., Bohren K.M., Sheikh-Hamad D. Osmotic response element enhancer activity. Regulation through p38 kinase and mitogen-activated extracellular signal-regulated kinase kinase. J. Biol. Chem. 274:1999;20185-20190.
275. Hsu S.C., Gavrilin M.A., Tsai M.H., Han J., Lai M.Z. p38 mitogen-activated protein kinase is involved in Fas ligand expression. J. Biol. Chem. 274:1999;25769-25776.
276. Zhou G., Bao Z.Q., Dixon J.E. Components of a new human protein kinase signal transduction pathway. J. Biol. Chem. 270:1995;12665-12669.
277. Lee J.D., Ulevitch R.J., Han J. Primary structure of BMK1: a new mammalian map kinase. Biochem. Biophys. Res. Commun. 213:1995;715-724.
278. Kasler H.G., Victoria J., Duramad O., Winoto A. ERK5 is a novel type of mitogen-activated protein kinase containing a transcriptional activation domain. Mol. Cell. Biol. 20:2000;8382-8389.
279. Luo H., Reidy M.A. Activation of big mitogen-activated protein kinase-1 regulates smooth muscle cell replication. Arterioscler. Thromb. Vasc. Biol. 22:2002;394-399.
280. Dinev D., Jordan B.W., Neufeld B., Lee J.D., Lindemann D., Rapp U.R., Ludwig S. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep. 2:2001;829-834.
281. Hayashi M., Tapping R.I., Chao T.H., Lo J.F., King C.C., Yang Y., Lee J.D. BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase. J. Biol. Chem. 276:2001;8631-8634.
282. Kato Y., Chao T.H., Hayashi M., Tapping R.I., Lee J.D. Role of BMK1 in regulation of growth factor-induced cellular responses. Immunol. Res. 21:2000;233-237.
283. Suzaki Y., Yoshizumi M., Kagami S., Koyama A.H., Taketani Y., Houchi H., Tsuchiya K., Takeda E., Tamaki T. Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults. J. Biol. Chem. 277:2002;9614-9621.
284. Kato Y., Tapping R.I., Huang S., Watson M.H., Ulevitch R.J., Lee J.D. BMK1/ERK5 is required for cell proliferation induced by epidermal growth factor. Nature. 395:1998;713-716.
285. Abe J., Kusuhara M., Ulevitch R.J., Berk B.C., Lee J.D. Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J. Biol. Chem. 271:1996;16586-16590.
286. Takeishi Y., Huang Q., Wang T., Glassman M., Yoshizumi M., Baines C.P., Lee J.D., Kawakatsu H., Che W., Lerner-Marmarosh N., Zhang C., Yan C., Ohta S., Walsh R.A., Berk B.C., Abe J. Src family kinase and adenosine differentially regulate multiple MAP kinases in ischemic myocardium: modulation of MAP kinases activation by ischemic preconditioning. J. Mol. Cell. Cardiol. 33:2001;1989-2005.
287. Takeishi Y., Huang Q., Abe J., Glassman M., Che W., Lee J.D., Kawakatsu H., Lawrence E.G., Hoit B.D., Berk B.C., Walsh R.A. Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch. J. Mol. Cell. Cardiol. 33:2001;1637-1648.
288. Abe J., Takahashi M., Ishida M., Lee J.D., Berk B.C. c-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1. J. Biol. Chem. 272:1997;20389-20394.
289. Hayashi Y., Iwashita T., Murakamai H., Kato Y., Kawai K., Kurokawa K., Tohnai I., Ueda M., Takahashi M. Activation of BMK1 via tyrosine 1062 in RET by GDNF and MEN2A mutation. Biochem. Biophys. Res. Commun. 281:2001;682-689.
290. English J.M., Pearson G., Hockenberry T., Shivakumar L., White M.A., Cobb M.H. Contribution of the ERK5/MEK5 pathway to Ras/Raf signaling and growth control. J. Biol. Chem. 274:1999;31588-31592.
291. Kamakura S., Moriguchi T., Nishida E. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases. Identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 274:1999;26563-26571.
292. Marinissen M.J., Gutkind J.S. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends Pharmacol. Sci. 22:2001;368-376.
293. Fukuhara S., Marinissen M.J., Chiariello M., Gutkind J.S. Signaling from G protein-coupled receptors to ERK5/Big MAPK 1 involves Galpha q and Galpha 12/13 families of heterotrimeric G proteins. Evidence for the existence of a novel Ras and Rho-independent pathway. J. Biol. Chem. 275:2000;21730-21736.
294. 2-terminal kinase, p38s, and extracellular signal-regulated kinase 5. Mol. Cell. Biol. 19:1999;4289-4301.
295. Chao T.-H., Hayashi M., Tapping R.I., Kato Y., Lee J.-D. MEKK3 directly regulates MEK5 activity as part of the big mitogen-activated protein kinase 1 (BMK1) signaling pathway. J. Biol. Chem. 274:1999;36035-36038.
296. Sun W., Kesavan K., Schaefer B.C., Garrington T.P., Ware M., Johnson N.L., Gelfand E.W., Johnson G.L. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. J. Biol. Chem. 276:2001;5093-5100.
297. Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J., Lee J.D. BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. EMBO J. 16:1997;7054-7066.
298. Yang C.C., Ornatsky O.I., McDermott J.C., Cruz T.F., Prody C.A. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Res. 26:1998;4771-4777.
299. Kato Y., Zhao M., Morikawa A., Sugiyama T., Chakravortty D., Koide N., Yoshida T., Tapping R.I., Yang Y., Yokochi T., Lee J.D. Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J. Biol. Chem. 275:2000;18534-18540.
300. Pearson G., English J.M., White M.A., Cobb M.H. ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation. J. Biol. Chem. 276:2001;7927-7931.
301. Kumar N.V., Bernstein L.R. Ten ERK-related proteins in three distinct classes associate with AP-1 proteins and/or AP-1 DNA. J. Biol. Chem. 276:2001;32362-32372.
302. Nakashima S., Wang S., Hisamoto N., Sakai H., Andoh M., Matsumoto K., Nozawa Y. Molecular cloning and expression of a stress-responsive mitogen-activated protein kinase-related kinase from Tetrahymena cells. J. Biol. Chem. 274:1999;9976-9983.
303. Schwahn D.J., Medina D. p96, a MAPK-related protein, is consistently downregulated during mouse mammary carcinogenesis. Oncogene. 17:1998;1173-1178.
304. Zhu A.X., Zhao Y., Moller D.E., Flier J.S. Cloning and characterization of p97MAPK, a novel human homologue of rat ERK-3. Mol. Cell. Biol. 14:1994;8202-8211.
305. Cheng M., Boulton T.G., Cobb M.H. ERK3 is a constitutively nuclear protein kinase. J. Biol. Chem. 271:1996;8951-8958.
306. Cheng M., Zhen E., Robinson M.J., Ebert D., Goldsmith E., Cobb M.H. Characterization of a protein kinase that phosphorylates serine 189 of the mitogen-activated protein kinase homolog ERK3. J. Biol. Chem. 271:1996;12057-12062.
307. Sauma S., Friedman E. Increased expression of protein kinase C beta activates ERK3. J. Biol. Chem. 271:1996;11422-11426.
308. Kim S.H., Yang Y.C. A specific association of ERK3 with B-Raf in rat hippocampus. Biochem. Biophys. Res. Commun. 229:1996;577-581.
309. Abe M.K., Kahle K.T., Saelzler M.P., Orth K., Dixon J.E., Rosner M.R. ERK7 is an autoactivated member of the MAPK family. J. Biol. Chem. 276:2001;21272-21279.
310. Qian Z., Okuhara D., Abe M.K., Rosner M.R. Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel. J. Biol. Chem. 274:1999;1621-1627.
311. Smith G.C., d'Adda di Fagagna F., Lakin N.D., Jackson S.P. Cleavage and inactivation of ATM during apoptosis. Mol. Cell. Biol. 19:1999;6076-6084.
312. Hotti A., Jarvinen K., Siivola P., Holtta E. Caspases and mitochondria in c-Myc-induced apoptosis: identification of ATM as a new target of caspases. Oncogene. 19:2000;2354-2362.
313. Tong X., Liu B., Dong Y., Sun Z. Cleavage of ATM during radiation-induced apoptosis: caspase-3-like apoptotic protease as a candidate. Int. J. Radiat. Biol. 76:2000;1387-1395.
314. Cortez D., Guntuku S., Qin J., Elledge S.J. ATR and ATRIP: partners in checkpoint signaling. Science. 294:2001;1713-1716.
315. Song Q., Lees-Miller S.P., Kumar S., Zhang Z., Chan D.W., Smith G.C., Jackson S.P., Alnemri E.S., Litwack G., Khanna K.K., Lavin M.F. DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J. 15:1996;3238-3246.
316. Song Q., Burrows S.R., Smith G., Lees-Miller S.P., Kumar S., Chan D.W., Trapani J.A., Alnemri E., Litwack G., Lu H., Moss D.J., Jackson S., Lavin M.F. Interleukin-1 beta-converting enzyme-like protease cleaves DNA-dependent protein kinase in cytotoxic T cell killing. J. Exp. Med. 184:1996;619-626.
317. Chan D.W., Lees-Miller S.P. The DNA-dependent protein kinase is inactivated by autophosphorylation of the catalytic subunit. J. Biol. Chem. 271:1996;8936-8941.
318. Soubeyrand S., Torrance H., Giffin W., Gong W., Schild-Poulter C., Hache R.J.G. Activation and autoregulation of DNA-PK from structural single-stranded DNA and coding end hairpins. Proc. Natl. Acad. Sci. U.S.A. 98:2001;9605-9610.
319. Douglas P., Moorhead G.B.G., Ye R., Lees-Miller S.P. Protein phosphatases regulate DNA-dependent kinase activity. J. Biol. Chem. 276:2001;18992-18998.
320. Bharti A., Kraeft S.-K., Gounder M., Pandey P., Jin S., Yuan Z.M., Lees-Miller S.P., Weichselbaum R., Weaver D., Chen L.B., Kufe D., Kharbanda S. Inactivation of DNA-dependent protein kinase by protein kinase Cδ: implications for apoptosis. Mol. Cell. Biol. 18:1998;6719-6728.
321. Kumar S., Pandey P., Bharti A., Jin S., Weichselbaum R., Weaver D., Kufe D., Kharbanda S. Regulation of DNA-dependent protein kinase by the Lyn tyrosine kinase. J. Biol. Chem. 273:1998;25654-25658.
322. Faderl S., Talpaz M., Estrov Z., O'Brien S., Kurzrock R., Kantarijian H.M. The biology of chronic myeloid leukemia. New Engl. J. Med. 341:1999;164-172.
323. Deutsch E., Dugray A., AbdulKarim B., Marangoni E., Maggiorella L., Vaganay S., M'Kacher R., Rasy S.D., Eschwege F., Vainchenker W., Turhan A.G., Bourhis J. Bcr-Abl down-regulates the DNA repair protein DNA-PKcs. Blood. 97:2001;2084-2090.
324. Echarri A., Pendergast A.M. Activated c-Abl is degraded by the ubiquitin-dependent proteasome pathway. Curr. Biol. 11:2001;1759-1765.
325. Haneda M., Sugimoto T., Kikkawa R. Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade. Eur. J. Pharmacol. 365:1999;1-7.
326. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:2000;186-192.
327. Manfroid I., Martial J.A., Muller M. Inhibition of protein phosphatase PP1 in GH3B6, but not in GH3 cells, activates the MEK/ERK/c-fos pathway and the human prolactin promoter, involving the coactivator CPB/p300. Mol. Endocrinol. 15:2001;625-637.
328. Sohaskey M.L., Ferrell J.E. Jr. Distinct, constitutively active MAPK phosphatases function in Xenopus oocytes: implications for p42 MAPK regulation in vivo. Mol. Biol. Cell. 10:1999;3729-3743.
329. Chung H., Brautigan D.L. Protein phosphatase 2A suppresses MAP kinase signalling and ectopic protein expression. Cell Signal. 11:1999;575-580.
330. Takekawa M., Maeda T., Saito H. Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO J. 17:1998;4744-4752.
331. Takekawa M., Adachi M., Nakahata A., Nakayama I., Itoh F., Tsukuda H., Taya Y., Imai K. p53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J. 19:2000;6517-6526.
332. Westermarck J., Li S.P., Kallunki T., Han J., Kahari V.M. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Mol. Cell. Biol. 21:2001;2373-2383.
333. Morita K., Saitoh M., Tobiume K., Matsuura H., Enomoto S., Nishitoh H., Ichijo H. Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. EMBO J. 20:2001;6028-6036.
334. Zou X., Tsutsui T., Ray D., Blomquist J.F., Ichijo H., Ucker D.S., Kiyokawa H. The cell cycle-regulatory Cdc25A phosphatase inhibits apoptosis signal-regulating kinase 1. Mol. Cell. Biol. 21:2001;4818-4828.
335. Shiozuka K., Watanabe Y., Ikeda T., Hashimoto S., Kawashima H. Cloning and expression of PCPTP1 encoding protein tyrosine phosphatase. Gene. 162:1995;279-284.
336. Ogata M., Sawada M., Fujino Y., Hamaoka T. cDNA cloning and characterization of a novel receptor-type protein tyrosine phosphatase expressed predominantly in the brain. J. Biol. Chem. 270:1995;2337-2343.
337. Hendriks W., Schepens J., Brugman C., Zeeuwen P., Wieringa B. A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain. Biochem. J. 305:1995;499-504.
338. Sharma E., Lombroso P.J. A neuronal protein tyrosine phosphatase induced by nerve growth factor. J. Biol. Chem. 270:1995;49-53.
339. Pulido R., Zuniga A., Ullrich A. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 17:1998;7337-7350.
340. Zuniga A., Torres J., Ubeda J., Pulido R. Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm. J. Biol. Chem. 274:1999;21900-21907.
341. Gronda M., Arab S., Iafrate B., Suzuki H., Zanke B.W. Hematopoietic protein tyrosine phosphatase suppresses extracellular stimulus-regulated kinase activation. Mol. Cell. Biol. 21:2001;6851-6858.
342. Blanco-Aparicio C., Torres J., Pulido R. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase. J. Cell Biol. 147:1999;1129-1136.
343. Sun H., Charles C.H., Lau L.F., Tonks N.K. MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell. 75:1993;487-493.
344. Ward Y., Gupta S., Jensen P., Wartmann M., Davis R.J., Kelly K. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature. 367:1994;651-654.
345. Guan K.L., Butch E. Isolation and characterization of a novel dual specific phosphatase, HVH2, which selectively dephosphorylates the mitogen-activated protein kinase. J. Biol. Chem. 270:1995;7197-7203.
346. Kwak S.P., Hakes D.J., Martell K.J., Dixon J.E. Isolation and characterization of a human dual specificity protein-tyrosine phosphatase gene. J. Biol. Chem. 269:1994;3596-3604.
347. Muda M., Boschert U., Dickinson R., Martinou J.C., Martinou I., Camps M., Schlegel W., Arkinstall S. MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J. Biol. Chem. 271:1996;4319-4326.
348. Martell K.J., Seasholtz A.F., Kwak S.P., Clemens K.K., Dixon J.E. hVH-5: a protein tyrosine phosphatase abundant in brain that inactivates mitogen-activated protein kinase. J. Neurochem. 65:1995;1823-1833.
349. Muda M., Boschert U., Smith A., Antonsson B., Gillieron C., Chabert C., Camps M., Martinou I., Ashworth A., Arkinstall S. Molecular cloning and functional characterization of a novel mitogen-activated protein kinase phosphatase, MKP-4. J. Biol. Chem. 272:1997;5141-5151.
350. Shin D.Y., Ishibashi T., Choi T.S., Chung E., Chung I.Y., Aaronson S.A., Bottaro D.P. A novel human ERK phosphatase regulates H-Ras and v-Raf signal transduction. Oncogene. 14:1997;2633-2639.
351. Dowd S., Sneddon A.A., Keyse S.M. Isolation of the human genes encoding the Pyst1 and Pyst2 phosphatases: characterization of Pyst2 as a cytosolic dual-specificity MAP kinase phosphatase and its catalytic activation by both MAP and SAP kinases. J. Cell Sci. 111:1998;3389-3399.
352. Tanoue T., Moriguchi T., Nishida E. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J. Biol. Chem. 274:1999;19949-19956.
353. Theodosiou A., Smith A., Gillieron C., Arkinstall S., Ashworth A. MKP-5, a new member of the MAP kinase phosphatase family, which selectively dephosphorylates stress-activated kinases. Oncogene. 18:1999;6981-6988.
354. Tanoue T., Yamamoto T., Maeda R., Nishida E. A novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs. J. Biol. Chem. 276:2001;26629-26639.
355. Matsuguchi T., Musikacharoen T., Johnson T.R., Kraft A.S., Yoshikai Y. A novel mitogen-activated protein kinase phosphatase is an important negative regulator of lipopolysaccharide-mediated c-Jun N-terminal kinase activation in mouse macrophage cell lines. Mol. Cell. Biol. 21:2001;6999-7009.
356. Camps M., Nichols A., Gillieron C., Antonsson B., Muda M., Chabert C., Boschert U., Arkinstall S. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science. 280:1998;1262-1265.
357. Fjeld C.C., Rice A.E., Kim Y., Gee K.R., Denu J.M. Mechanistic basis for catalytic activation of mitogen-activated protein kinase phosphatase 3 by extracellular signal-regulated kinase. J. Biol. Chem. 275:2000;6749-6757.
358. Sohaskey M.L., Ferrell J.E. Jr. Activation of p42 mitogen-activated protein kinase (MAPK), but not c-Jun NH(2)-terminal kinase, induces phosphorylation and stabilization of MAPK phosphatase XCL100 in Xenopus oocytes. Mol. Biol. Cell. 13:2002;454-468.
359. Groom L.A., Sneddon A.A., Alessi D.R., Dowd S., Keyse S.M. Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J. 15:1996;3621-3632.
360. Muda M., Theodosiou A., Gillieron C., Smith A., Chabert C., Camps M., Boschert U., Rodrigues N., Davies K., Ashworth A., Arkinstall S. The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity. J. Biol. Chem. 273:1998;9323-9329.
361. Muda M., Theodosiou A., Rodrigues N., Boschert U., Camps M., Gillieron C., Davies K., Ashworth A., Arkinstall S. The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J. Biol. Chem. 271:1996;27205-27208.
362. Zama T., Aoki R., Kamimoto T., Inoue K., Ikeda Y., Hagiwara M. A novel dual-specificity phosphatase SKRP1 interacts with the MAPKK MKK7 and inactivates the JNK MAPK pathway: implication for the precise regulation of the particular MAPK pathway. J. Biol. Chem. 277:2002;23909-23918.
363. Zama T., Aoki R., Kamimoto T., Inoue K., Ikeda Y., Hagiwara M. Scaffold role of a MAP kinase phosphatase, SKRP1 for the JNK signaling pathway. J. Biol. Chem. 277:2002;23919-23926.
364. Shen Y., Luche R., Wei B., Gordon M.L., Diltz C.D., Tonks N.K. Activation of the JNK signaling pathway by a dual-specificity phosphatase, JSP-1. Proc. Natl. Acad. Sci. U.S.A. 98:2001;13613-13618.
365. Fanger G.R. Regulation of the MAPK family members: role of subcellular localization and architectural organization. Histol. Histopathol. 14:1999;887-894.
366. Dziegielewski J., Beerman T.A. Cellular responses to the DNA strand-scission enediyne C-1027 can be independent of the PI-3 kinases ATM, ATR and DNA-PK. J. Biol. Chem. 277:2002;20549-20554.